Navigation Links
Federal Judicial Panel Considering Byetta Lawsuit Consolidation, Rottenstein Law Group LLP Reports

(PRWEB) August 25, 2013

The Byetta lawyers at Rottenstein Law Group LLP report that a federal judicial panel is still considering the consolidation of Byetta lawsuits, according to court documents. The Judicial Panel on Multidistrict Litigation was set to begin discussions on July 25 to investigate a consolidation of proceedings for pretrial efficiency.

Byetta, manufactured by Bristol-Myers Squibb subsidiary Amylin Pharmaceuticals, is designed to treat type-2 diabetes. The plaintiffs in the cases for the drugs all have common cause for suit, alleging that they suffered the same potentially dangerous side effects, such as pancreatitis and thyroid cancer, according to court documents in In RE: Incretin Mimetics Products Liability Litigation (MDL-2452; U.S. Judicial Panel on Multidistrict Litigation).

A March 2013 announcement* by the U.S. Food and Drug Administration mentioned findings similar to the allegations of the plaintiffs: That the drug caused inflammation of the pancreas and pre-cancerous changes to the cells of the pancreas. Byetta was also found to potentially increase the risk of thyroid cancer, according to the FDA.**

The Rottenstein Law Group LLP encourages those who believe they have suffered from the alleged adverse side effects of Byetta to download a free brochure that features information about the drug’s side effects and lawsuits.


The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Updated SSRI Birth Defects Lawsuits Allegations: Resource4thePeople Reports Cases Continue to Be Filed as Key Hearing Set in Consolidated Federal Litigation
2. Vaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Settlement in Second Bellwether Trial in Federal C.R. Bard Mesh Litigation
3. DePuy Pinnacle Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal Pinnacle Hip Litigation
4. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal GranuFlo Recall Litigation
5. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Latest Defense Motion in Federal DePuy ASR Recall Litigation
6. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Start of Second Bellwether Trial in Federal C.R. Bard Litigation
7. Mirena Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Orders in Federal Multidistrict Litigation for Mirena IUD Lawsuits
8. Biomet Hip Lawsuits Update: Almost 600 Lawsuits Pending in Federal Court, Reports Rottenstein Law Group LLP
9. America’s Health Insurance Announces Plans to Become a Registered and Certified Agent in the Federal Health Insurance Marketplace Exchange- Currently in Training
10. Vaginal Mesh Lawsuits Proceed Against Ethicon, as Bernstein Liebhard LLP Notes Order for Discovery Conferences in Federal Ethicon Litigation
11. Biomet Hip Lawsuits Mount, as Claims in Federal Litigation Approach 600, Bernstein Liebhard LLP Reports
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Holcomb ... the leading plastic surgery practices in Florida, is proud to announce that Dr. ... surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. , Ethicon is ...
(Date:11/30/2015)... ... November 30, 2015 , ... The successful filing of an Investigational New Drug ... so important to this key industry segment, Regis Technologies has decided to sponsor and ... 4th at 11am EST. , Federal law does not allow new drugs to cross ...
(Date:11/30/2015)... ... November 30, 2015 , ... Healthjump, Inc. ... Inc., a Healthcare IT consulting, development and support company. The purchase will expand ... available within DataTrade to extend the services currently provided by Healthjump. ...
(Date:11/30/2015)... ... November 30, 2015 , ... GKhair & Tibolli team members and artists were ... held on November 8th and 9th at the Puerto Rico Convention Center, San Juan ... beauticians and top of the line fashion journalists. The San Juan Beauty Show carries ...
(Date:11/30/2015)... ... 2015 , ... Innovaacom, a leading provider of medical education ... of educational needs for pharmacists worldwide. The poll of pharmacists in Europe, Asia, ... online and face-to-face education for pharmacists who are fast becoming the new “gatekeepers” ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... HANOVER, N.J. , Nov. 30, 2015  Novartis ... portfolio at the 57 th American Society of ... leukemias, lymphomas and myelomas as well as supportive care, ... in addition to personalized cell therapies. The ASH Annual ... Orlando, Florida . Novartis Oncology . ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
(Date:11/30/2015)... 2015 Elbit Imaging Ltd. (TASE, ... today that it was informed by InSightec Ltd. ("InSightec"), that ... has approved its Exablate Neuro system to treat movement, ... --> Insightec,s Exablate Neuro platform is transforming ... two technologies: Focused Ultrasound, which is used to lesion ...
Breaking Medicine Technology: